Angiography-Derived Versus Wire-Based Physiological Assessment of Intermediate Coronary Lesions—A Non-Inferiority Meta-Analysis and Systematic Review
Open Access
- 28 October 2026
- journal article
- review article
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (11) , 546
Abstract
Background: Wire-based methods-fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) are the gold standard for physiological assessment of intermediate coronary lesions, but procedural complexity limits their use. Angiography-derived methods estimate FFR without a pressure wire or hyperemic agent. Direct evidence comparing angiography-derived with wire-based methods remains inconsistent. We assessed whether angiography-derived methods are non-inferior to wire-based methods for assessment of intermediate lesions and their impact on procedural burden. Methods: We systematically searched for randomized controlled trials (RCT). The primary outcome was major adverse cardiac events a composite of all-cause mortality (MACE), myocardial infarction, and revascularization at 12 months. Non-inferiority was assessed using a risk-difference (RD) margin of 3.0%. Secondary outcomes included fluoroscopy and procedure times, contrast volume, individual components of MACE, stent thrombosis, stroke, and procedural complications. Results: Three RCTs comprising 6141 patients (3089 [50.3%] assigned to angiography-derived methods) were included. MACE did not differ between groups (RD 0.85%; 95% confidence interval (CI) −2.92 to 4.62%; p = 0.436); the upper CI crossed the 3.0% non-inferiority margin. Fluoroscopy time was significantly shorter with angiography-derived methods, whereas total procedure time, contrast volume, and other secondary outcomes were comparable. Using angiography-derived methods led to more index revascularizations. Conclusions: MACE did not differ significantly between angiography-derived and wire-based methods for physiological assessment of intermediate coronary lesions. However, non-inferiority of angiography-derived methods could not be established. They led to a modestly lower fluoroscopy time, but more index revascularizations without any difference in total procedure time and contrast used.Keywords
This publication has 31 references indexed in Scilit:
- Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trialThe Lancet, 2024
- Angiography-derived physiological patterns of coronary artery disease: implications with post-stenting physiology and long-term clinical outcomesClinical Research in Cardiology, 2024
- GRADE Guidance 34: update on rating imprecision using a minimally contextualized approachJournal of Clinical Epidemiology, 2022
- Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trialThe Lancet, 2021
- Influence of lesion and disease subsets on the diagnostic performance of the quantitative flow ratio in real-world patientsScientific Reports, 2021
- Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia ParadigmJACC, 2020
- Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart DiseaseJACC, 2020
- Diagnostic performance of quantitative flow ratio in prospectively enrolled patients: An individual patient‐data meta‐analysisCatheterization and Cardiovascular Interventions, 2019
- Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary InterventionNew England Journal of Medicine, 2009
- Percutaneous Coronary Intervention of Functionally Nonsignificant StenosisJACC, 2007